Contribution of Erector Spina Plane Block to Analgesia for Myofascial Pain Syndrome
Study Details
Study Description
Brief Summary
Myofascial pain syndrome is a common chronic disease characterized by pain and tenderness in one or more muscle groups. It is characterized by myofascial trigger points that are felt as a band or a nodule harder than normal consistency located in the muscle. Myofascial trigger points are developes as a result of muscle injury ; this can be acute trauma caused by sport injury, accident, or chronic muscle overuse by repetitive occupational activities, emotional stress or poor posture. Trigger point injection is the application of low dose local anesthetic drug into the trigger point.Its main purpose is to weaken the trigger point caused by muscle spasm.However, it may reduce pain partially or have a short duration of action, so it may need to be repeated several times at regular intervals.Trigger point injection can reach trigger points in superficial muscles With the erector spina plane block technique, more effective and long-term pain treatment can be achieved by reaching deeper trigger points. With this hypothesis, we aimed to investigate the contribution of the erector spina plane block to trigger point injection in the treatment of myofascial pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Myofascial pain syndrome is a common chronic disease characterized by pain and tenderness in one or more muscle groups. It is characterized by myofascial trigger points that are felt as a band or a nodule harder than normal consistency located in the muscle. Myofascial trigger points are developes as a result of muscle injury ; this can be acute trauma caused by sport injury, accident, or chronic muscle overuse by repetitive occupational activities, emotional stress or poor posture. Trigger point injection is the application of low dose local anesthetic drug into the trigger point.Its main purpose is to weaken the trigger point caused by muscle spasm.However, it may reduce pain partially or have a short duration of action, so it may need to be repeated several times at regular intervals.Trigger point injection can reach trigger points in superficial muscles With the erector spina plane block technique, more effective and long-term pain treatment can be achieved by reaching deeper trigger points. With this hypothesis, we aimed to investigate the contribution of the erector spina plane block to trigger point injection in the treatment of myofascial pain.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Trapezius Muscle İnjection (TMI) group TMI group will receive ultrasound guided trapezius muscle injection two times with one week interval. Pain severity of the patients will evaluate by visual analog scale before (week 0) and after (week 1,2,3,4) the injections |
Procedure: trapezius muscle injection
TMI group will receive ultrasound guided trapezius muscle injection two times with one week interval.
|
Active Comparator: Erector Spina Plane Block (ESPB) group ESPB group in the 1th week will receive ultrasound guided trapezius muscle injection and in the 2nd week ultrasound guided erector spina plane block will receive. Pain severity of the patients will evaluate by visual analog scale before (week 0) and after (week 1,2,3,4) the injections |
Procedure: trapezius muscle injection
TMI group will receive ultrasound guided trapezius muscle injection two times with one week interval.
Procedure: erector spina plane block
1th week will receive ultrasound guided trapezius muscle injection and in the 2nd week ultrasound guided erector spina plane block will receive
|
Outcome Measures
Primary Outcome Measures
- VAS (visual analog scale ) score [before injection (week 0)]
Severity of pain The patient rated pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.
- VAS (visual analog scale ) score [1st week after injection]
Severity of pain The patient rated pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.
- VAS (visual analog scale ) score [2nd week after injection]
Severity of pain The patient rated pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.
- VAS (visual analog scale ) score [3rd week after injection]
Severity of pain The patient rated pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.
- VAS (visual analog scale ) score [4th weeks after injection]
Severity of pain The patient rated pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst pain imaginable.
Eligibility Criteria
Criteria
Inclusion Criteria:
Clinical diagnosis of Myofascial pain
Exclusion Criteria:
Cervical radiculopathy fibromyalgia
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dişkapi Reserch and Education Hospital | Ankara | Turkey |
Sponsors and Collaborators
- Diskapi Teaching and Research Hospital
Investigators
- Principal Investigator: damla yürük, Diskapi Teaching and Research Hospital
- Study Director: ömer taylan akkaya, Diskapi Teaching and Research Hospital
- Study Chair: Hüseyin Alp Alptekin, Diskapi Teaching and Research Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- DiskapiTRH Algology